No quarterly revenue total was found in KRAIG BIOCRAFT LABORATORIES, INC.'s SEC filings.
Kraig Biocraft Laboratories, Inc. (KBLB) files with the SEC under industry code 2820, Plastic Material, Synth Resin/Rubber, Cellulos (No Glass). Free cash flow was -$627,303. As of Jun 30, 2026 it held $3.4 million in cash and investments and $194,007 in total debt.
Revenue
—
Net income
$-909,535
-25.3% vs year-ago quarter
Operating cash flow
$-598,695
-35.1% vs year-ago quarter
Free cash flow
$-627,303
-40.4% vs year-ago quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
1.10B
+5.5% vs year-ago quarter
Net cash
$3.20M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (SIC 2820)
- Listed as
- KBLB (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- WY
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1413119
- Former names
- Kraig Biocraft Laboratories, Inc (until May 20, 2025)
Other Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) companies
- Celanese Corp CE
- EIDP, Inc. CTA-PB
All 3 Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$703,433 | -$825,500 | -$722,668 | -$1.4M | -$637,745 |
| Net income | -$909,535 | -$942,720 | -$787,621 | -$1.5M | -$726,133 |
| Diluted EPS | $0.00 | $0.00 | -$0.00 | $0.00 | $0.00 |
| Operating cash flow | -$598,695 | -$529,718 | -$449,487 | -$461,859 | -$443,125 |
| Free cash flow | -$627,303 | -$543,834 | -$451,099 | -$461,859 | -$446,908 |
| Total assets | $4.3M | $3.7M | $2.6M | $2.4M | $1.6M |
| Total liabilities | $11.0M | $10.8M | $10.6M | $10.3M | $10.1M |
| Stockholders' equity | -$6.8M | -$7.1M | -$8.0M | -$8.0M | -$8.5M |
| Cash and investments | $3.4M | $2.9M | $1.8M | $1.6M | $785,462 |
| Total debt | $194,007 | $18,190 | $171,162 | $184,030 | $58,776 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
All 384 Kraig Biocraft Laboratories, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.